Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.

Abstract

Vinorelbine has moderate activity in advanced or recurrent squamous cell carcinoma of the cervix. Further studies of combination regimens with this agent are justified in this patient population.